With the progression of tumor malignancy, expression of PKCα revealed a significant elevation compared with the other PKC isotypes: PKCα mRNA expression ranked fourth in 5637 (stage II), second in T24 (stage III) and first in TCC-SUP (stage IV). The gene discussed is PRRT2; the disease is neoplasm.